# CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)

URL: https://app.greenveil.ai/ingredients/ingredient_unii_4_q93_rcw27_e
Categories: pharma
Identifier: chembl:CHEMBL2108997

> CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED). Route: OPHTHALMIC; Dosage form: GEL; Potency: 4 %w/w Compiled from 3 published data sources.

## Safety assessment

- Chemical concern: not yet assessed
- Is it a concern? We haven't assessed a concern score for this ingredient yet.
- Rationale: Route: OPHTHALMIC; Dosage form: GEL; Potency: 4 %w/w

## Regulatory status

- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: GEL; Potency: 4 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 103 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: EMULSION; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 85 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 300 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT, AUGMENTED; Maximum daily exposure: 23 mg
- US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 150 mg
- US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: GEL, METERED; Maximum daily exposure: 50 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer.

## Data sources

- FDA Inactive Ingredient Database (updated 2026-01-09): https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-database-download
- FDA GSRS UNII (updated 2026-02-26): https://precision.fda.gov/uniisearch/
- openFDA Substance (updated 2026-05-24): https://api.fda.gov/other/substance.json?search=unii:4Q93RCW27E

_Assessed by Greenveil._